Skip to main content
CV logo

CV · CapsoVision, Inc · Webcasts, Transcripts & Audio

Track CV — free
$6.45 +0.28 (+4.54%)
Market Cap
$321.30M
Shares
50.05M
Volume · Oct 5 27.4K Avg daily vol (3M) 166.68K

CapsoVision, Inc Webcasts

Earnings calls, investor updates, investor days and conferences for CapsoVision, Inc (CV), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Earnings call
FY26 · Q2
2026-08-13
CapsoVision, Inc (CV) Q2 2026 Earnings Call Transcript
Confident tone CapsuCam Colon development FDA clearance of AI Highlights CapsuCam Plus commercial growth
Revenue
$3.64M
▲ 9.9% YoY
Diluted EPS
$-0.15
Gross margin
51.4%
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-14
CapsoVision, Inc (CV) Q1 2026 Earnings Call Transcript
Positive tone AI-assisted reading (AI Highlights) CAPSO-10 UGI / pancreatic cancer program Commercial / installed base performance
Revenue
$2.79M
▲ 0.3% YoY
Diluted EPS
$-0.15
Gross margin
47.6%
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-03-26
CapsoVision, Inc (CV) Q4 2025 Earnings Call Transcript
Confident tone FDA regulatory pathway and timing CapsuleCam UGI / pancreatic cancer initiative CapsuleCam Colon Gen2 program
Revenue
$3.92M*
Gross margin
49.9%
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Conference
Investor event
2026-03-23
CapsoVision, Inc (CV) March 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY25 · Q3
2025-11-13
CapsoVision, Inc (CV) Q3 2025 Earnings Call
Revenue
$3.54M
▲ 19.3% YoY
Diluted EPS
$-0.17
Gross margin
54.1%
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-14
CapsoVision, Inc (CV) Q2 2025 Earnings Call
Revenue
$3.31M
▲ 16.6% YoY
Diluted EPS
$-2.02
Gross margin
54.6%
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–6 of 6 webcasts
Key facts CIK 1378325 CUSIP 140935107 13F (30d) 1 filings 1 filers Visit website Investor relations